본문 바로가기
KERD
논문KCI 등재

만성 기침 환자의 천식 진단을 위한 호산구 탈과립 단백의 효용성

The Efficacy of Eosinophilic Degranulation Proteins for Diagnosing Asthma in Chronic Cough Patients

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류임상병리학

초록

Background: Chronic cough is a common non-specific symptom and has various causes including asthma. Objective: The aims of this study were to compare eosinophilic degranulation in the airways between chronic cough patients with and without asthma and to evaluate correlations between sputum eosinophils and eosinophilic degranulation proteins. Method: Thirty-seven patients with chronic cough and 9normal individuals (control group) were enrolled. Patients with chronic cough were divided into 2 groups based on positivity for bronchial hyperresponsiveness (BHR): those with asthma (asthma group, n=18) and those without asthma (non-asthma group, n=19). Sputum levels of eosinophilderived neurotoxin (EDN) and major basic protein (MBP)levels were measured, and eosinophil counts were performed in all patients. Result: Sputum % eosinophils were increased in both the asthma and non-asthma groups compared to the control group. However, sputum EDN/MBP levels were increased only in the asthma group compared to the non-asthma and control groups. Sputum % eosinophils correlated positively with sputum EDN/MBP levels in the asthma group, but not in the Non-asthma group. Conclusion: Increased EDN/MBP levels and significant correlations between % eosinophils and EDN/MBP levels were observed only in the asthma group, suggesting that eosinophil degranulation proteins could be a marker for identifying chronic cough due to asthma.

Abstract

Background: Chronic cough is a common non-specific symptom and has various causes including asthma. Objective: The aims of this study were to compare eosinophilic degranulation in the airways between chronic cough patients with and without asthma and to evaluate correlations between sputum eosinophils and eosinophilic degranulation proteins. Method: Thirty-seven patients with chronic cough and 9normal individuals (control group) were enrolled. Patients with chronic cough were divided into 2 groups based on positivity for bronchial hyperresponsiveness (BHR): those with asthma (asthma group, n=18) and those without asthma (non-asthma group, n=19). Sputum levels of eosinophilderived neurotoxin (EDN) and major basic protein (MBP)levels were measured, and eosinophil counts were performed in all patients. Result: Sputum % eosinophils were increased in both the asthma and non-asthma groups compared to the control group. However, sputum EDN/MBP levels were increased only in the asthma group compared to the non-asthma and control groups. Sputum % eosinophils correlated positively with sputum EDN/MBP levels in the asthma group, but not in the Non-asthma group. Conclusion: Increased EDN/MBP levels and significant correlations between % eosinophils and EDN/MBP levels were observed only in the asthma group, suggesting that eosinophil degranulation proteins could be a marker for identifying chronic cough due to asthma.

참고문헌 (24)

  1. Irwin RS, "The spectrum and frequency of causes, key component of the diagnostic evaluation, and outcome of specific therapy", Am Rev Respir Dis, 141, pp.640~7 (1990)
  2. Poe RH, "Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol", Chest, 95, pp.723~8 (1989)
  3. Pratter MR, "An algorithmic approach to chronic cough", Ann Intern Med, 119, pp.977~83 (1993)
  4. O’Connel F, "Capsaicin cough sensitivity decreases with successful treatment of chronic cough", Am J Respir Crit Care Med, 150, pp.374~80 (1994)
  5. Fujimura M, "Importance of atopic cough, cough variant asthma and sinobronchial syndrome as cause of chronic cough in the Hokuriku area of Japan", Respirology, 10, pp.201~7 (2005)
  6. Niimi A, "Nature of airway inflammation and remodeling in chronic cough", J Allergy Clin Immunol, 166, pp.565~70 (2005)
  7. Bousquet J, "Eosinophilic inflammation in asthma", N Engl J Med, 323, pp.1033~9 (1990)
  8. Ohashi Y, "Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma", Am Rev Respir Dis, 154, pp.1469~76 (1992)
  9. Wardlaw AJ, "Eosinophils in asthma and other allergic diseases", Br Med Bull, 56, pp.985~1003 (2000)
  10. Kay AB, "Asthma and inflammation", J Allergy Clin Immunol, 87, pp.893~910 (1991)
  11. Venge P, "Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease", Clin Exp Allergy, 29, pp.1172~86 (1999)
  12. Pizzichini E, "Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements", Am J Respir Crit Care Med, 154, pp.308~17 (1996)
  13. Fahy JV, "Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects", Am Rev Respir Dis, 147, pp.1126~31 (1993)
  14. Yazicioglu M, "The significance of sputum ECP levels in differential diagnosis of asthma in children", J Asthma, 36, pp.493~502 (1999)
  15. Yoo Y, "Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine", Allergy, 59, pp.1055~62 (2004)
  16. Brightling CE, "Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma", Am J Respir Crit Care Med, 162, pp.878~82 (2000)
  17. Fujimoto K, "Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease", Eur Respir J, 25, pp.640~6 (2005)
  18. Rytila P, "Eosinophilic airway inflammation as an underlying mechanism of undiagnosed prolonged cough in primary healthcare patients", Respir Med, 96, pp.52~8 (2002)
  19. Fujimoto K, "Sputum eosinophilia and bronchial responsiveness in patients with chronic non-productive cough responsive to anti-asthma therapy", Respirology, 8, pp.168~74 (2003)
  20. Sedgwick JB, "Peripheral blood eosinophilis from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin", J Allergy Clin Immunol, 114, pp.568~74 (2004)
  21. Kim KW, "Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma", Lung, 185, pp.97~103 (2007)
  22. Wassom DL, "Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia", J Clin Invest, 67, pp.651~61 (1981)
  23. Gundel RH, "Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates", J Clin Invest, 87, pp.1470~3 (1991)
  24. Li SH, "Expression of eosinophil major basic protein mRNA in bronchial asthma", Nan Fang Yi Ke Da Xue Xue Bao, 26, pp.1330~3 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (11건)